Studies indicate that up to 40% of cancer patients in the United States utilize cannabis, but just a third of doctors feel confident providing advice. Research on this subject is also challenging due to federal legislation prohibiting university researchers from distributing or possessing cannabis for research purposes. Exceptions include if it is government-issued or pharmaceutical-grade.